Johanna I Kiiski

5PUBLICATIONS
21CO-AUTHORS
Gene and molecular therapyCell and nuclear divisionPharmacogenomicsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 02, 2026
Identification of a Functional CYP2C8 Variant Allele that Alters Splicing, Reduces Protein Expression, and Increases Drug Exposure.

|Feb 23, 2025
Genetic and Functional Characterization of DPYD Exon 4 Deletion Common in the Finnish Population.

Johanna I Kiiski, Sofia Khan, Antti Hosio

|Feb 21, 2025
A Phenotyping Tool for Seven Cytochrome P450 Enzymes and Two Transporters: Application to Examine the Effects of Clopidogrel and Gemfibrozil.

Laura Aurinsalo, Outi Lapatto-Reiniluoto, Mika Kurkela

|Oct 03, 2023
Ticagrelor Increases Exposure to the Breast Cancer Resistance Protein Substrate Rosuvastatin.

Minna Lehtisalo, E Katriina Tarkiainen, Mikko Neuvonen

|Aug 08, 2023
CYP2C19 loss-of-function alleles and use of omeprazole or esomeprazole increase the risk of cardiovascular outcomes in patients using clopidogrel.

Markus Ramste, Markus Ritvos, Sergei Häyrynen

Pageof 1

Frequent Collaborators

4 joint publications

Mikko Neuvonen

4 joint publications

Mikko Niemi

3 joint publications

Janne T Backman

2 joint publications

Outi Lapatto-Reiniluoto